COVID-19

UK government strengthen their pandemic preparedness with H5 influenza vaccine

In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.

Schools need Gov approved cleaning procedures & clear safety standards

Graham Mimms, Hygiene Aviation Expert and co-founder of Safe Surface Sensor, explains why the only way to stop a future health crisis is to ensure we have strict hygiene policies in place.

COVID-19 vaccines & genetic modification

Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.

Safe NHS environments: For patient, clinician & support worker

Kate Edwards, Director at Intelligent Infection Control Services Limited, LumiBio, underlines the importance of creating safe environments for the patient, clinician & support worker in the NHS.

Dogs can sniff out coronavirus with 96% accuracy

According to a new study, led by the University of Pennsylvania, specially trained detection dogs can sniff out positive COVID-19 samples with 96% accuracy.

Rapid COVID-19 test kit receives scientific seal of approval

Researchers from Simon Fraser University have approved a faster, cheaper COVID-19 test kit that could expand more widespread rapid testing.

Parliament and Council agree on EU Digital COVID Certificate proposal

The European Parliament and the Council have reached an agreement on the Commission's proposal of the EU Digital COVID Certificate.

Commission signs third contract for 1.8 billion BioNTech-Pfizer doses

The European Commission has announced that it has signed a third contract to secure an additional 1.8 billion BioNTech-Pfizer vaccine doses.

Logistics & supply chain will win the COVID-19 war

Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.

Pfizer vaccine produces greater antibody response when given at 12 weeks

A new study has found that the second dose of the Pfizer vaccine produces a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks.

Global bioinformatics surveillance: SARS-CoV-2 variant detection tests

Shiao Yee, Marketing Communications Manager, Novacyt Group, discusses how global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests.

What lasting legacies of COVID-19 will local government take forward?

Lorraine Smith, Divisional Managing Director at Civica, discusses how the pandemic has not only re-shaped local government when it comes to new ways of working but also in transforming citizen engagement.

Communication strategies are critical for vaccine rollout

Adam Enterkin, Global SVP Sales at BlackBerry, explores the critical role of secure crisis communications for the vaccine rollout and the value of a communication strategy to combat misinformation.

Study examines immune responses to COVID in patients with antibody deficiencies

A new study aims to explore the immune response to COVID-19 infection and vaccination in patients with antibody deficiencies.

Why COVID vaccine development was exceptionally speedy

Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.

COVID-19 vaccine does not damage placentas

Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.

HIV patients are more likely to die from COVID-19

In a new study, researchers have found that individuals living with HIV and AIDS have an increased risk of death from COVID-19 infection.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders